LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000038.6:c.4348C>T
APC
· NP_000029.2:p.(Arg1450Ter)
· NM_000038.6
GRCh37: chr5:112175639 C>T
·
GRCh38: chr5:112839942 C>T
Gene:
APC
Transcript:
NM_000038.6
Final call
Likely Pathogenic
PVS1 very strong
PS4 supporting
Variant details
Gene
APC
Transcript
NM_000038.6
Protein
NP_000029.2:p.(Arg1450Ter)
gnomAD AF
0.0 (v2.1)
ClinVar
Pathogenic
OncoKB
Likely Oncogenic
Classification rationale
Interpretation summary
Generated evidence synthesis
1
Pathogenic evidence: the APC VCEP assigns PVS1 very strong to this codon-1450 nonsense variant.
2
Pathogenic evidence: two unrelated FAP probands provide 1.5 phenotype points, meeting the APC VCEP PS4 supporting threshold.
Final determination:
APC VCEP Rule20 classifies a variant as Likely Pathogenic when one PVS1 very strong criterion and one qualifying supporting pathogenic criterion are satisfied; here these are PVS1 and PS4.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Met | Met, very strong: nonsense codon 1450 lies within the APC VCEP's codon 49–2645 interval assigned full PVS1. |
vcep_apc_specifications_supplementary_material_v2
vcep_fig_1_apc_pvs1_decision_tree_2023_10_20
pvs1_variant_assessment
cspec
PMID:26446593
PMID:21110124
|
| PS1 | N/A | Not applicable: the APC VCEP limits PS1 to missense or splice variants, whereas c.4348C>T produces the nonsense change p.Arg1450Ter. |
vcep_apc_specifications_supplementary_material_v2
PMID:26446593
PMID:21110124
|
| PS2 | Not assessed | Not assessed: two affected probands are reported, but no parental testing or de novo determination is available to assign the VCEP's 1- or 2-point score. |
vcep_apc_specifications_supplementary_material_v2
vcep_table_1_262
PMID:26446593
PMID:21110124
|
| PS3 | Not assessed | Not assessed: no exact-variant RNA or qualifying protein assay result is available to meet the APC VCEP PS3 functional-study requirements. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| PS4 | Met | Met at Supporting: two unrelated FAP probands contribute 1.5 APC phenotype points, matching the VCEP 1–1.5-point Supporting threshold. |
cspec
vcep_apc_specifications_supplementary_material_v2
vcep_table_1_262
PMID:26446593
PMID:21110124
|
| PM1 | N/A | Not applicable: the APC VCEP marks PM1 Not Applicable and identifies no approved APC pathogenic missense hotspot or critical-domain route for residue 1450. |
vcep_apc_specifications_supplementary_material_v2
|
| PM2 | Not assessed | Not assessed: VCEP-required non-cancer gnomAD allele count and frequency are unknown because the query failed. |
vcep_apc_specifications_supplementary_material_v2
gnomad_v2
|
| PM3 | N/A | Not applicable: the APC VCEP marks PM3 not applicable for familial adenomatous polyposis. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| PM4 | N/A | Not applicable: APC VCEP PM4 is not used, and this variant is nonsense rather than an in-frame or stop-loss change. |
vcep_apc_specifications_supplementary_material_v2
|
| PM5 | N/A | Not applicable: PM5 is restricted by the APC VCEP to missense variants at positions 1026 or 1028, while this variant is nonsense at Arg1450. |
vcep_apc_specifications_supplementary_material_v2
|
| PM6 | Not assessed | Not assessed: affected probands are reported, but neither source documents assumed de novo status or the parental information required for the VCEP PM6 score. |
vcep_apc_specifications_supplementary_material_v2
vcep_table_1_262
PMID:26446593
PMID:21110124
|
| PP1 | Not assessed | Not assessed: no affected relatives with matching genotypes or segregation data are reported, so the VCEP's minimum 3-meiosis threshold cannot be evaluated. |
vcep_apc_specifications_supplementary_material_v2
vcep_table_1_262
PMID:26446593
PMID:21110124
|
| PP2 | N/A | Not applicable: the APC VCEP explicitly marks PP2 Not Applicable, and the case variant is a nonsense rather than missense variant. |
vcep_apc_specifications_supplementary_material_v2
|
| PP3 | N/A | Not applicable: c.4348C>T is a nonsense variant, while the APC PP3 rule names presumed-missense splicing effects and non-canonical splicing variants. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| PP4 | N/A | Not applicable: the APC VCEP states PP4 is already captured by PS4 and cannot be used as independent evidence. |
vcep_apc_specifications_supplementary_material_v2
|
| PP5 | N/A | Not applicable: the APC VCEP does not use PP5 without the primary evidence underlying an expert opinion. |
vcep_apc_specifications_supplementary_material_v2
|
| BA1 | Not assessed | Not assessed: the VCEP-required non-cancer gnomAD v2.1 Popmax frequency is unknown because that query failed. |
vcep_apc_specifications_supplementary_material_v2
gnomad_v2
|
| BS1 | Not assessed | Not assessed: the VCEP-required non-cancer gnomAD v2.1 Popmax frequency is unknown, so the 0.001% BS1 threshold cannot be evaluated. |
vcep_apc_specifications_supplementary_material_v2
gnomad_v2
|
| BS2 | Not assessed | Not assessed: VCEP-relevant non-cancer gnomAD homozygote data are unavailable because the query failed. |
vcep_apc_specifications_supplementary_material_v2
gnomad_v2
|
| BS3 | Not assessed | Not assessed: no exact-variant assay demonstrates preserved APC function, comparable beta-catenin activity, or absence of mRNA aberration under the VCEP BS3 requirements. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| BS4 | Not assessed | Not assessed: no affected noncarrier is documented, so the VCEP's 0.5-point minimum for BS4 Supporting cannot be evaluated. |
vcep_apc_specifications_supplementary_material_v2
vcep_table_1_262
PMID:26446593
PMID:21110124
|
| BP1 | N/A | Not applicable: BP1 is a missense criterion, whereas c.4348C>T is a nonsense variant at codon 1450, outside the codon 1021-1035 exception. |
vcep_apc_specifications_supplementary_material_v2
|
| BP2 | Not assessed | Not assessed: two reports lack documented trans phase, or at least three unknown-phase occurrences with different pathogenic APC variants, required by the VCEP. |
cspec
vcep_apc_specifications_supplementary_material_v2
PMID:26446593
PMID:21110124
|
| BP3 | N/A | Not applicable: APC VCEP BP3 is not used, and the variant is a nonsense substitution rather than an in-frame repeat-region indel. |
vcep_apc_specifications_supplementary_material_v2
|
| BP4 | N/A | Not applicable: c.4348C>T is a nonsense variant, whereas APC BP4 addresses synonymous or intronic variants with multiple no-impact splice predictions. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| BP5 | Not assessed | Not assessed: no alternate pathogenic adenomatous-polyposis gene variant is documented for the required colorectal polyposis phenotype. |
vcep_apc_specifications_supplementary_material_v2
|
| BP6 | N/A | Not applicable: the APC VCEP does not use BP6 for unsupported benign expert opinions. |
vcep_apc_specifications_supplementary_material_v2
|
| BP7 | N/A | Not applicable: c.4348C>T is a coding nonsense variant, not the synonymous or intronic variant required by the APC BP7 rule. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.